Ian Kennedy, MBBS

Articles by Ian Kennedy, MBBS

Paclitaxel as First-Line Treatment for Metastatic Breast Cancer

ByJames F. Bishop, MD, MBBS,Martin H. Tattersall, MD, MB,Joanna Dewar, MBBS,Guy C. Toner, MD, MBBS,Ian N. Olver, MD, MBBS,Stephen Ackland, MBBS,Ian Kennedy, MBBS,David Goldstein, MBBS,Howard Gurney, MBBS,Euan Walpole, MBBS,John Levi, MD, MBBS,Jennifer Stephenson, MSc

April 1st 1997

When administered as a single agent in pretreated patients with advanced breast cancer, paclitaxel (Taxol) exhibits remarkable antitumor activity. This trial was undertaken to compare paclitaxel with standard

Latest Updated Articles

Paclitaxel as First-Line Treatment for Metastatic Breast Cancer
Published: April 1st 1997 | Updated:

Ian Kennedy, MBBS

Articles by Ian Kennedy, MBBS

Paclitaxel as First-Line Treatment for Metastatic Breast Cancer

Latest Updated Articles

Trending on CancerNetwork

ADCE-D01 Earns FDA Fast Track Designation in Soft Tissue Sarcoma

KRd Appears to Exhibit Greater Outcomes in Standard-Risk Multiple Myeloma

Serplulimab Plus Chemo Meets EFS End Point in Early-Stage Gastric Cancer

212Pb-Dotamtate Prolongs Responses in Advanced GEP-NETs

CD20 Bispecifics vs CAR T: Evaluating CRS and ICANS in Lymphoma